ADARs, RNA editing and more in hematological malignancies

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Adenosine-to-inosine (A-to-I) editing is the most common RNA editing in humans, catalyzed by ADAR enzymes.
• ADARs function in the nucleus and cytoplasm, converting adenosine to inosine on double-stranded RNA.
• Dysregulated ADAR activity is a hallmark of numerous cancers.

Purpose of the Study:

• To review the functions of ADARs in cancer.
• To specifically highlight ADARs' roles in hematological malignancies.
• To discuss RNA editing-independent ADAR functions and therapeutic potential.

Main Methods:

• Literature review of ADARs' functions in cancer.
• Focus on recent findings in hematological malignancies.
• Exploration of therapeutic strategies targeting RNA editing.

Main Results:

• ADARs play significant roles in the development and progression of various cancers.
• Specific functions and implications of ADARs in hematological malignancies are increasingly understood.
• ADARs possess functions beyond RNA editing, impacting cellular processes.

Conclusions:

• ADARs are critical regulators in cancer, especially hematological malignancies.
• Understanding ADARs' multifaceted roles opens avenues for novel cancer therapies.
• Targeting RNA editing presents a promising therapeutic strategy for cancer treatment.